首页 > 最新文献

Addiction最新文献

英文 中文
Disentangling debate about therapeutic and recreational use of psychedelics 解开关于迷幻药的治疗和娱乐用途的争论。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-15 DOI: 10.1111/add.16744
Christina Andrews, Wayne Hall, Keith Humphreys, John Marsden
<p>We thank the commentators for their thoughtful responses to our article [<span>1</span>]. The commentators appear to agree that the liberalization of access to psychedelics seems likely to continue apace, that carefully constructed and regulatory policy will be required, and that policy should be guided by rigorous science.</p><p>The commentators raise a number of other important considerations that are worthy of further discussion. Kilmer [<span>2</span>] identifies several unique regulatory matters that apply to psychedelics. First, because psychedelics are used much less frequently than alcohol or tobacco, common policy tools—such as a taxes and minimum unit pricing—will be less effective in influencing their consumption. Second, the role of supervision in the use of psychedelics takes regulators into unfamiliar terrain. For example, the authorities in Oregon and Colorado have moved to allow access to psilocybin only under the supervision of a licensed facilitator.</p><p>Zullino [<span>3</span>] contends that we have conflated debates about the regulation of psychedelic-assisted treatment with legalization of psychedelics for non-therapeutic purposes. In fact, this conflation has been driven by some advocates who have sought to achieve recreational legalization under a veneer of medicine. The risk to public health is that the limited evidence for the therapeutic benefits of psychedelics will be used to justify access under liberal regulations that will facilitate both ineffective therapies and non-therapeutic use in much the same way that ‘medical’ cannabis legalization has done [<span>4</span>].</p><p>A compelling body of evidence may emerge in the future to support some therapeutic uses of psychedelics; but this is by no means a forgone conclusion. Even if there is stronger evidence on the effectiveness of psychedelic-assisted treatments for mental health conditions, it may be difficult to separate the regulation of psychedelics for therapeutic and recreational purposes (e.g. it can be hard to differentiate existential anxiety over a lack of meaning in life from an anxiety disorder). Of course, if the public wants to legalize for recreational use they can; but if medical claims are being made, our job as scientists is to evaluate their strength and the risks of bias.</p><p>We appreciate and agree with Bogenschutz's [<span>5</span>] observation that many people are already using psychedelic drugs in an effort to treat psychiatric and substance use disorders in the absence of good evidence on their safety and effectiveness. Such experimentation has been encouraged by uncritical media coverage of the putative benefits and safety of these drugs. Experience with the off-label prescribing of ketamine for a wide range of behavioral health disorders is a cautionary example of how medical practice can get ahead of the science. To avoid replicating the pitfalls of cannabis liberalization with the psychedelics, it is critical that governments clearl
{"title":"Disentangling debate about therapeutic and recreational use of psychedelics","authors":"Christina Andrews,&nbsp;Wayne Hall,&nbsp;Keith Humphreys,&nbsp;John Marsden","doi":"10.1111/add.16744","DOIUrl":"10.1111/add.16744","url":null,"abstract":"&lt;p&gt;We thank the commentators for their thoughtful responses to our article [&lt;span&gt;1&lt;/span&gt;]. The commentators appear to agree that the liberalization of access to psychedelics seems likely to continue apace, that carefully constructed and regulatory policy will be required, and that policy should be guided by rigorous science.&lt;/p&gt;&lt;p&gt;The commentators raise a number of other important considerations that are worthy of further discussion. Kilmer [&lt;span&gt;2&lt;/span&gt;] identifies several unique regulatory matters that apply to psychedelics. First, because psychedelics are used much less frequently than alcohol or tobacco, common policy tools—such as a taxes and minimum unit pricing—will be less effective in influencing their consumption. Second, the role of supervision in the use of psychedelics takes regulators into unfamiliar terrain. For example, the authorities in Oregon and Colorado have moved to allow access to psilocybin only under the supervision of a licensed facilitator.&lt;/p&gt;&lt;p&gt;Zullino [&lt;span&gt;3&lt;/span&gt;] contends that we have conflated debates about the regulation of psychedelic-assisted treatment with legalization of psychedelics for non-therapeutic purposes. In fact, this conflation has been driven by some advocates who have sought to achieve recreational legalization under a veneer of medicine. The risk to public health is that the limited evidence for the therapeutic benefits of psychedelics will be used to justify access under liberal regulations that will facilitate both ineffective therapies and non-therapeutic use in much the same way that ‘medical’ cannabis legalization has done [&lt;span&gt;4&lt;/span&gt;].&lt;/p&gt;&lt;p&gt;A compelling body of evidence may emerge in the future to support some therapeutic uses of psychedelics; but this is by no means a forgone conclusion. Even if there is stronger evidence on the effectiveness of psychedelic-assisted treatments for mental health conditions, it may be difficult to separate the regulation of psychedelics for therapeutic and recreational purposes (e.g. it can be hard to differentiate existential anxiety over a lack of meaning in life from an anxiety disorder). Of course, if the public wants to legalize for recreational use they can; but if medical claims are being made, our job as scientists is to evaluate their strength and the risks of bias.&lt;/p&gt;&lt;p&gt;We appreciate and agree with Bogenschutz's [&lt;span&gt;5&lt;/span&gt;] observation that many people are already using psychedelic drugs in an effort to treat psychiatric and substance use disorders in the absence of good evidence on their safety and effectiveness. Such experimentation has been encouraged by uncritical media coverage of the putative benefits and safety of these drugs. Experience with the off-label prescribing of ketamine for a wide range of behavioral health disorders is a cautionary example of how medical practice can get ahead of the science. To avoid replicating the pitfalls of cannabis liberalization with the psychedelics, it is critical that governments clearl","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 2","pages":"213-214"},"PeriodicalIF":5.2,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16744","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142826727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Society for the Study of Addiction Annual Conference 2024 SSA年会摘要,2024年11月14-15日,英国泰恩河畔纽卡斯尔
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-12 DOI: 10.1111/add.16709
<p><b>SSAConf24_2_1</b></p><p><b>Developing an instrument to estimate risk of funding-related bias in gambling research</b></p><p>M. M. Young<sup>1</sup>, S. Stark<sup>2</sup>, J. Rogers<sup>3</sup>, A. Roberts<sup>4</sup>, C. M. Baxter<sup>2</sup>, S. Dymond<sup>5</sup>, E. A. Ludvig<sup>6</sup>, S. Sharman<sup>7</sup>, R. J. Tunney<sup>8</sup>, K. Tuico<sup>2</sup> and A. Dapo-Famodu<sup>2</sup></p><p><sup>1</sup><i>Greo Evidence Insights; Carleton University; Canadian Centre on Substance Use and Addiction;</i> <sup>2</sup><i>Greo Evidence Insights;</i> <sup>3</sup><i>School of Health and Social Care, University of Lincoln;</i> <sup>4</sup><i>School of Psychology, University of Lincoln;</i> <sup>5</sup><i>School of Psychology, Swansea University; Department of Psychology, Reykjavík University;</i> <sup>6</sup><i>Department of Psychology, University of Warwick;</i> <sup>7</sup><i>National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London;</i> <sup>8</sup><i>School of Psychology, Aston University</i></p><p>Research funded by sources with a vested interest in the outcomes of that research introduces a risk of funding-related bias. This risk has been an issue of concern in multiple domains, including alcohol, tobacco and medical research. One area in which the issue has been a topic of much debate is the study of gambling-related harms; however, there is currently no evidence-based method of identifying research that may have a high or low risk of funding-related bias.</p><p>This project aims to develop a reliable, valid instrument to estimate the risk of funding-related bias in gambling studies. To do so, the following activities are being undertaken: (1) conducting a rapid search of the literature to review past work in related fields; (2) conducting a modified e-Delphi study with international researchers and funders to identify factors that contribute to risk of funding-related bias and their weights; and (3) developing and validating an instrument to assess risk of funding-related bias. Further details on the study can be found in the protocol on Open Science Framework: https://osf.io/vncp5/.</p><p>This tool will be able to support several outcomes, including outlining information for inclusion in funding calls and disclosure statements and improving understanding of the impact of funding source on research area and design and the subsequent potential for influence on policy and legislation.</p><p><b>Disclosures</b></p><p>M.M. Young is Greo Evidence Insights (Greo)* liaison with the Academic Forum for the Study Gambling (AFSG)** and was employed for 12 years by the Canadian Centre on Substance Use and Addiction, which received funding from the Government of Canada.</p><p>S. Stark is the Director of Research and Evidence Services at Greo Evidence Insights (Greo)*. Prior to 2022, S. Stark was employed at the Responsible Gambling Council, where, in the past 5 years, she worked on projects funded by the
[j] .博彩研究中资金相关偏差风险评估方法研究[j]。M. Young1, S. Stark2, J. Rogers3, A. Roberts4, C. M. Baxter2, S. Dymond5, E. A. Ludvig6, S. Sharman7, R. J. Tunney8, K. tuic2, A. dapo - famodu21;卡尔顿大学;加拿大药物使用和成瘾问题中心;2Greo Evidence Insights;3林肯大学卫生与社会关怀学院;4美国林肯大学心理学院;5斯旺西大学心理学院;Reykjavík大学心理学系;6英国华威大学心理学系;7伦敦国王学院精神病学、心理学和神经科学研究所国家成瘾中心;由对研究结果有既得利益的来源资助的研究,会带来与资助相关的偏见风险。这一风险已成为包括酒精、烟草和医学研究在内的多个领域关注的问题。这个问题一直备受争议的一个领域是对赌博相关危害的研究;然而,目前还没有基于证据的方法来确定可能存在高或低风险的资助相关偏倚的研究。该项目旨在开发一种可靠、有效的工具,以估计赌博研究中与资金相关的偏见的风险。为此,正在进行以下活动:(1)快速检索文献,以审查相关领域的过去工作;(2)与国际研究人员和资助者进行改进的e-Delphi研究,以确定导致资金相关偏倚风险的因素及其权重;(3)开发和验证一种评估资金相关偏倚风险的工具。关于该研究的进一步细节可在开放科学框架协议中找到:https://osf.io/vncp5/.This工具将能够支持若干成果,包括概述用于供资呼吁和披露声明的信息,以及提高对供资来源对研究领域和设计的影响以及随后对政策和立法的潜在影响的理解。Young是Greo Evidence Insights (Greo)*与赌博研究学术论坛(AFSG)**的联络人,并在加拿大物质使用和成瘾中心工作了12年,该中心获得了加拿大政府的资助。Stark是Greo Evidence Insights (Greo)*的研究和证据服务总监。在2022年之前,S. Stark在负责任赌博委员会工作,在过去的5年里,她参与了由安大略省酒精和博彩委员会(加拿大),卡尔顿大学(加拿大),Greo(加拿大),国际负责任博彩中心(美国),内华达大学拉斯维加斯分校国际博彩监管中心(美国),美高梅国际度假村(美国),GambleAware(英国),Camelot Group(英国)和Playtech(英国)资助的项目。罗杰斯是AFSG执行委员会的联合主席**,为此他每年获得一笔酬金。J. Rogers获得了国家健康研究所(NIHR)、林肯郡议会、诺丁汉郡议会和阿什菲尔德区议会的资助。罗伯茨是AFSG执行委员会的联合主席**,为此她每年获得一笔酬金。A. Roberts获得了来自成瘾研究协会、Greo*、国家卫生研究院、林肯郡议会、阿什菲尔德区议会、威尔士卫生与保健研究中心、林肯公共卫生和桑坦德银行的资助。她在赌博或博彩业方面没有任何潜在的利益冲突。Baxter是Greo Evidence Insights (Greo)*的高级研究分析师。Greo在过去5年中从安大略省卫生和长期护理部(加拿大)、非营利组织、慈善机构和高等教育机构(加拿大)获得了资金。Greo还从加拿大国有企业(即国家垄断企业)的社会责任部门获得资金,这些部门负责管理省级/地区赌博,监管结算基金(英国),第三部门慈善机构(英国)和国际监管机构。戴蒙德是AFSG执行委员会的外联联合主席**,他每年都会收到一笔酬金。在过去的5年里,他获得了来自威尔士健康与护理研究中心、威尔士政府科学办公室、威尔士基础设施研究基金、赌博意识、赌博委员会(监管解决方案)、Greo*、英国皇家空军慈善基金、武装部队契约基金信托基金、退伍军人事务办公室健康创新基金、英国学院/Leverhulme信托基金、布里斯托尔赌博危害研究中心和国际负责任游戏中心的资助。他是威尔士赌博研究、教育和治疗(GREAT)网络的主任,该网络由威尔士政府通过威尔士健康和护理研究(HCRW)资助。 基于这一证据,我们使用COM-B(能力、机会、动机、行为)诊断来确定三种创新干预措施的重点和内容:(1)针对11 - 13岁青少年的教育资源,重点关注使年轻人能够管理向青春期过渡和接触非法物质的技能;(2) 1-1专家干预,指导11-16岁已经使用违禁药物的青少年进行治疗干预;(3)公共卫生运动的材料,教育11 - 14岁的青少年有关非法药物及其影响的知识,并指明可信赖的信息来源。我将讨论我们在项目中面临的挑战,以及我们正在进行的改进和评估干预措施的工作。雷兹勒没有任何利益需要申报。道尔没有利益需要申报。珀西-史密斯没有要申报的利益。故c项为正确答案。伦诺克斯没有利益要申报,r。冈恩没有利益要申报。当事人没有利益需要申报。里斯没有要申报的利益。ssaconf24_12_3在英格兰为16-25岁的年轻人制定和实施一项多成分的毒品和酒精外展服务。韦尔奇1、杜克2、桑蒂2、赖特1、《改变,成长,生活》;在英格兰,在过去的十年中,年轻人的非法药物使用和与毒品相关的危害有所增加,而针对年轻人的药物使用支持的专门提供和转介却有所减少。由于年轻人没有意识到其中的风险,娱乐性毒品的使用经常被正常化。自2018年以来,一项开创性的“1625外展”服务向英格兰德比郡城市和农村环境中16-25岁的年轻人提供了普遍、选择性和指示性的毒品预防干预措施。这一独特的多要素模式旨在通过教育、响应性外联、节日摊位、夜间经济干预和有针对性的社交媒体宣传活动,提高知识、技能和复原力,从而减少对非法药物和相关危险行为的需求。干预措施以多机构利益攸关方的投入为指导,针对风险最高的关键过渡点最易受吸毒影响的人。这可以支持不同的、服务不足的群体,这些群体通常不参与服务。我们的工作详细说明了如何操作一个多组件、共同生产的模型,其可翻译性和可持续性以及展示其影响的方法。韦尔奇没有要申报的利益。Duke没有要申报的利益。甘地没有利益需要申报。赖特没有利益要申报。英国目前关于治疗药物使用和精神健康问题同时发生的指导方针在实践中得到了执行吗?Swithenbank1, P. Parkes1, J. Puddephatt2, P. Irizar3, K. Jackson4, A. O 'Donnell4, C. Drummond5, C. Angus1, A. Ushakova1, F. Lobban1, L. goodwin11兰卡斯特大学;2边山大学;3曼彻斯特大学;4纽卡斯尔大学;背景和目的药物使用和精神健康问题通常同时发生,导致发病率和死亡率增加。在英国,目前关于治疗共存问题的指南(NICE, 2017;PHE 2016)为这一人群制定了工作标准。通过二次定性分析和系统回顾,我们旨在确定这些指导方针的实施程度。方法对ADEPT (Alcohol use disorder and DEpression Prevention and Treatment,酒精使用障碍和抑郁症预防与治疗)研究的访谈记录(n = 39名同时患有抑郁症和危险/有害酒精使用的成年人)进行定性分析。此外,还进行了一项系统综述,以确定自
{"title":"Society for the Study of Addiction Annual Conference 2024","authors":"","doi":"10.1111/add.16709","DOIUrl":"10.1111/add.16709","url":null,"abstract":"&lt;p&gt;&lt;b&gt;SSAConf24_2_1&lt;/b&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;Developing an instrument to estimate risk of funding-related bias in gambling research&lt;/b&gt;&lt;/p&gt;&lt;p&gt;M. M. Young&lt;sup&gt;1&lt;/sup&gt;, S. Stark&lt;sup&gt;2&lt;/sup&gt;, J. Rogers&lt;sup&gt;3&lt;/sup&gt;, A. Roberts&lt;sup&gt;4&lt;/sup&gt;, C. M. Baxter&lt;sup&gt;2&lt;/sup&gt;, S. Dymond&lt;sup&gt;5&lt;/sup&gt;, E. A. Ludvig&lt;sup&gt;6&lt;/sup&gt;, S. Sharman&lt;sup&gt;7&lt;/sup&gt;, R. J. Tunney&lt;sup&gt;8&lt;/sup&gt;, K. Tuico&lt;sup&gt;2&lt;/sup&gt; and A. Dapo-Famodu&lt;sup&gt;2&lt;/sup&gt;&lt;/p&gt;&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;i&gt;Greo Evidence Insights; Carleton University; Canadian Centre on Substance Use and Addiction;&lt;/i&gt; &lt;sup&gt;2&lt;/sup&gt;&lt;i&gt;Greo Evidence Insights;&lt;/i&gt; &lt;sup&gt;3&lt;/sup&gt;&lt;i&gt;School of Health and Social Care, University of Lincoln;&lt;/i&gt; &lt;sup&gt;4&lt;/sup&gt;&lt;i&gt;School of Psychology, University of Lincoln;&lt;/i&gt; &lt;sup&gt;5&lt;/sup&gt;&lt;i&gt;School of Psychology, Swansea University; Department of Psychology, Reykjavík University;&lt;/i&gt; &lt;sup&gt;6&lt;/sup&gt;&lt;i&gt;Department of Psychology, University of Warwick;&lt;/i&gt; &lt;sup&gt;7&lt;/sup&gt;&lt;i&gt;National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London;&lt;/i&gt; &lt;sup&gt;8&lt;/sup&gt;&lt;i&gt;School of Psychology, Aston University&lt;/i&gt;&lt;/p&gt;&lt;p&gt;Research funded by sources with a vested interest in the outcomes of that research introduces a risk of funding-related bias. This risk has been an issue of concern in multiple domains, including alcohol, tobacco and medical research. One area in which the issue has been a topic of much debate is the study of gambling-related harms; however, there is currently no evidence-based method of identifying research that may have a high or low risk of funding-related bias.&lt;/p&gt;&lt;p&gt;This project aims to develop a reliable, valid instrument to estimate the risk of funding-related bias in gambling studies. To do so, the following activities are being undertaken: (1) conducting a rapid search of the literature to review past work in related fields; (2) conducting a modified e-Delphi study with international researchers and funders to identify factors that contribute to risk of funding-related bias and their weights; and (3) developing and validating an instrument to assess risk of funding-related bias. Further details on the study can be found in the protocol on Open Science Framework: https://osf.io/vncp5/.&lt;/p&gt;&lt;p&gt;This tool will be able to support several outcomes, including outlining information for inclusion in funding calls and disclosure statements and improving understanding of the impact of funding source on research area and design and the subsequent potential for influence on policy and legislation.&lt;/p&gt;&lt;p&gt;&lt;b&gt;Disclosures&lt;/b&gt;&lt;/p&gt;&lt;p&gt;M.M. Young is Greo Evidence Insights (Greo)* liaison with the Academic Forum for the Study Gambling (AFSG)** and was employed for 12 years by the Canadian Centre on Substance Use and Addiction, which received funding from the Government of Canada.&lt;/p&gt;&lt;p&gt;S. Stark is the Director of Research and Evidence Services at Greo Evidence Insights (Greo)*. Prior to 2022, S. Stark was employed at the Responsible Gambling Council, where, in the past 5 years, she worked on projects funded by the ","PeriodicalId":109,"journal":{"name":"Addiction","volume":"119 S1","pages":"3-13"},"PeriodicalIF":5.2,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16709","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142816669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disentangling the temporal relationship between alcohol-related attitudes and heavy episodic drinking in adolescents within a randomized controlled trial. 在一项随机对照试验中,解开青少年酒精相关态度与重度间歇性饮酒之间的时间关系。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-10 DOI: 10.1111/add.16721
Andrew Percy, R Noah Padgett, Michael T McKay, Jon C Cole, Gregor Burkhart, Chloe Brennan, Harry R Sumnall

Background and aims: Within many alcohol prevention interventions, changes in alcohol-related attitudes (ARA) are often proposed as precursors to changes in drinking behaviour. This study aimed to measure the longitudinal relationship between ARA and behaviour during the implementation of a large-scale prevention trial.

Design and setting: This study was a two-arm school-based clustered randomized controlled trial. A total of 105 schools in Northern Ireland and Scotland participated in the Steps Towards Alcohol Misuse Prevention Programme (STAMPP) Trial.

Participants: A sample of 12 738 pupils (50% female; mean age = 12.5 years at baseline) self-completed questionnaires on four occasions (T1-T4). The final data sweep (T4) was 33 months post baseline.

Measurements: Individual assessments of ARA and heavy episodic drinking (HED) were made at each time-point. Additional covariates included location, school type, school socio-economic status and intervention arm. Estimated models examined the within-individual autoregressive and cross-lagged effects between ARA and HED across the four time-points (Bayes estimator).

Findings: All autoregressive effects were statistically significant for both ARA and HED across all time-points. Past ARA predicted future ARA [e.g. ARAT1 → ARAT2 = 0.071, credibility interval (CI) = 0.043-0.099, P < 0.001, one-tailed]. Similarly, past HED predicated future HED (e.g. HEDT1 → HEDT2 = 0.303, CI = 0.222-0.382, P < 0.001, one-tailed). Autoregressive effects for HED were larger than those for ARA at all time-points. In the cross-lagged effects, past HED statistically significantly predicted more positive ARA in the future (e.g. HEDT2 → ARAT3 = 0.125, CI = 0.078-0.173, P < 0.001, one tailed) except for the initial T1-T2 path. In contrast, past ARA did not predict future HED across any time-points.

Conclusions: Changes in alcohol-related attitudes were not a precursor to changes in heavy episodic drinking within the Steps Towards Alcohol Misuse Prevention Programme (STAMPP) Trial in Scotland and Northern Ireland. Rather, alcohol-related attitudes were more likely to reflect prior drinking status than predict future status. Heavy episodic drinking status appears to have a greater impact on future alcohol attitudes than attitudes do on future heavy episodic drinking.

背景和目的:在许多酒精预防干预措施中,酒精相关态度(ARA)的改变通常被认为是饮酒行为改变的前兆。本研究旨在测量在大规模预防试验实施期间ARA与行为之间的纵向关系。设计与背景:本研究为两组以学校为基础的聚类随机对照试验。北爱尔兰和苏格兰共有105所学校参加了“防止酗酒步骤方案”试验。参与者:12738名学生(50%为女生;平均年龄为基线时12.5岁)4次(T1-T4)自行填写问卷。最终数据扫描(T4)是在基线后33个月。测量方法:在每个时间点对ARA和重度发作性饮酒(HED)进行个体评估。其他协变量包括地点、学校类型、学校社会经济地位和干预部门。估计模型检查了ARA和HED在四个时间点之间的个体内自回归和交叉滞后效应(贝叶斯估计器)。结果:ARA和HED在所有时间点上的所有自回归效应均具有统计学意义。过去的ARA预测未来的ARA[例如,ARAT1→ARAT2 = 0.071,可信区间(CI) = 0.043-0.099, P T1→HEDT2 = 0.303, CI = 0.222-0.382, P T2→ARAT3 = 0.125, CI = 0.078-0.173, P]结论:在苏格兰和北爱尔兰的酒精滥用预防计划(STAMPP)试验中,酒精相关态度的改变并不是重度间歇性饮酒改变的前兆。相反,与酒精有关的态度更有可能反映出以前的饮酒状况,而不是预测未来的状况。重度偶发性饮酒状况对未来饮酒态度的影响似乎大于态度对未来重度偶发性饮酒的影响。
{"title":"Disentangling the temporal relationship between alcohol-related attitudes and heavy episodic drinking in adolescents within a randomized controlled trial.","authors":"Andrew Percy, R Noah Padgett, Michael T McKay, Jon C Cole, Gregor Burkhart, Chloe Brennan, Harry R Sumnall","doi":"10.1111/add.16721","DOIUrl":"https://doi.org/10.1111/add.16721","url":null,"abstract":"<p><strong>Background and aims: </strong>Within many alcohol prevention interventions, changes in alcohol-related attitudes (ARA) are often proposed as precursors to changes in drinking behaviour. This study aimed to measure the longitudinal relationship between ARA and behaviour during the implementation of a large-scale prevention trial.</p><p><strong>Design and setting: </strong>This study was a two-arm school-based clustered randomized controlled trial. A total of 105 schools in Northern Ireland and Scotland participated in the Steps Towards Alcohol Misuse Prevention Programme (STAMPP) Trial.</p><p><strong>Participants: </strong>A sample of 12 738 pupils (50% female; mean age = 12.5 years at baseline) self-completed questionnaires on four occasions (T1-T4). The final data sweep (T4) was 33 months post baseline.</p><p><strong>Measurements: </strong>Individual assessments of ARA and heavy episodic drinking (HED) were made at each time-point. Additional covariates included location, school type, school socio-economic status and intervention arm. Estimated models examined the within-individual autoregressive and cross-lagged effects between ARA and HED across the four time-points (Bayes estimator).</p><p><strong>Findings: </strong>All autoregressive effects were statistically significant for both ARA and HED across all time-points. Past ARA predicted future ARA [e.g. ARA<sub>T1</sub> → ARA<sub>T2</sub> = 0.071, credibility interval (CI) = 0.043-0.099, P < 0.001, one-tailed]. Similarly, past HED predicated future HED (e.g. HED<sub>T1</sub> → HED<sub>T2</sub> = 0.303, CI = 0.222-0.382, P < 0.001, one-tailed). Autoregressive effects for HED were larger than those for ARA at all time-points. In the cross-lagged effects, past HED statistically significantly predicted more positive ARA in the future (e.g. HED<sub>T2</sub> → ARA<sub>T3</sub> = 0.125, CI = 0.078-0.173, P < 0.001, one tailed) except for the initial T1-T2 path. In contrast, past ARA did not predict future HED across any time-points.</p><p><strong>Conclusions: </strong>Changes in alcohol-related attitudes were not a precursor to changes in heavy episodic drinking within the Steps Towards Alcohol Misuse Prevention Programme (STAMPP) Trial in Scotland and Northern Ireland. Rather, alcohol-related attitudes were more likely to reflect prior drinking status than predict future status. Heavy episodic drinking status appears to have a greater impact on future alcohol attitudes than attitudes do on future heavy episodic drinking.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on Qeadan et al.: Leveraging opportunities to expand the substance use disorder treatment arsenal 对Qeadan等人的评论:利用机会扩大物质使用障碍治疗库。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-10 DOI: 10.1111/add.16725
Ty S. Schepis

Many efficacious behavioral and medication treatments exist for substance use disorders (SUDs), but these treatments often have important limitations. Behavioral options that include cognitive–behavioral therapy and contingency management can effectively treat a variety of SUDs [1, 2], but these interventions are limited by their expense, availability of trained clinicians and the motivation and time commitment required of those seeking treatment [3, 4]. SUD medications are similarly impacted by access, cost and motivational barriers [3], with further structural barriers in some countries [5, 6] resulting from unique concerns about the potential for misuse or diversion of highly effective opioid agonist treatments [7]. Along with these limitations, many individuals with SUD may not benefit from a specific treatment, highlighting the need for ongoing medication and behavioral therapy development.

Qeadan et al. [8] provide intriguing evidence that glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists are linked to reduced incidence of alcohol intoxication and opioid overdose in individuals with alcohol use disorder or opioid use disorder, respectively. Using electronic health record (EHR) data from a US sample, they found a 50% reduction in the incidence of medical visits for alcohol intoxication and a 40% reduction in the incidence of opioid overdose. When combined with animal evidence [9] and emerging but more mixed evidence from human experimental and observational studies [10-12], Qeadan et al.’s [8] methodological perspective strengthens the case for double-blind, randomized controlled trials (RCTs) to evaluate the effectiveness of these medications for SUD. Indeed, the diverse sets of methodologies and samples that support effectiveness of GIP and GLP-1 receptor agonists further increase the case for RCTs, and addictions research needs these diverse methodological perspectives to truly understand the causes and develop treatments for SUD.

Ty S. Schepis: Conceptualization; funding acquisition; writing - original draft.

T.S.S. receives research support from the US National Institute on Drug Abuse, the US Substance Abuse and Mental Health Services Administration and the US Food and Drug Administration.

{"title":"Commentary on Qeadan et al.: Leveraging opportunities to expand the substance use disorder treatment arsenal","authors":"Ty S. Schepis","doi":"10.1111/add.16725","DOIUrl":"10.1111/add.16725","url":null,"abstract":"<p>Many efficacious behavioral and medication treatments exist for substance use disorders (SUDs), but these treatments often have important limitations. Behavioral options that include cognitive–behavioral therapy and contingency management can effectively treat a variety of SUDs [<span>1, 2</span>], but these interventions are limited by their expense, availability of trained clinicians and the motivation and time commitment required of those seeking treatment [<span>3, 4</span>]. SUD medications are similarly impacted by access, cost and motivational barriers [<span>3</span>], with further structural barriers in some countries [<span>5, 6</span>] resulting from unique concerns about the potential for misuse or diversion of highly effective opioid agonist treatments [<span>7</span>]. Along with these limitations, many individuals with SUD may not benefit from a specific treatment, highlighting the need for ongoing medication and behavioral therapy development.</p><p>Qeadan <i>et al.</i> [<span>8</span>] provide intriguing evidence that glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists are linked to reduced incidence of alcohol intoxication and opioid overdose in individuals with alcohol use disorder or opioid use disorder, respectively. Using electronic health record (EHR) data from a US sample, they found a 50% reduction in the incidence of medical visits for alcohol intoxication and a 40% reduction in the incidence of opioid overdose. When combined with animal evidence [<span>9</span>] and emerging but more mixed evidence from human experimental and observational studies [<span>10-12</span>], Qeadan <i>et al.</i>’s [<span>8</span>] methodological perspective strengthens the case for double-blind, randomized controlled trials (RCTs) to evaluate the effectiveness of these medications for SUD. Indeed, the diverse sets of methodologies and samples that support effectiveness of GIP and GLP-1 receptor agonists further increase the case for RCTs, and addictions research needs these diverse methodological perspectives to truly understand the causes and develop treatments for SUD.</p><p><b>Ty S. Schepis:</b> Conceptualization; funding acquisition; writing - original draft.</p><p>T.S.S. receives research support from the US National Institute on Drug Abuse, the US Substance Abuse and Mental Health Services Administration and the US Food and Drug Administration.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 2","pages":"251-252"},"PeriodicalIF":5.2,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142805657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of smoke-free policies in multi-unit housing with smoking behavior and second-hand smoke exposure: A systematic review. 多单元住房无烟政策与吸烟行为和二手烟暴露的关系:一项系统综述。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-06 DOI: 10.1111/add.16724
Heike H Garritsen, Farzana Khan, Andrea D Rozema, Ana Navas-Acien, Diana Hernández

Background and aim: Although considerable progress has been made regarding the implementation of smoke-free policies (SFPs), many people continue to be exposed to second-hand smoke (SHS) in the home environment. The aim of this study was to conduct a systematic review on the association of SFPs in multi-unit housing (MUH) with smoking behavior and SHS exposure.

Methods: In August 2022, we searched five online databases: PubMed, Embase, Web of Science, PsycINFO and CENTRAL. Keywords included terms for SFPs, MUH, smoking behavior and exposure to SHS. We searched for studies that focused on regular combustible cigarettes. Due to the high heterogeneity in methodology and outcomes of the included studies, a meta-analysis was not performed.

Results: Our search yielded 4750 articles. All of them were screened (24 based on full-text), and 17 met the inclusion criteria. All studies were published between 2001 and 2022. Most studies were conducted in the United States (n = 16) and used a cross-sectional design (n = 7) or a longitudinal design (n = 7). Seven studies evaluated smoking behavior. Five of them reported that SFPs in MUH were statistically significantly associated with decreases in either current smoking, smoking quantity, smoking frequency or smoking cessation. Fourteen studies evaluated exposure to SHS. Ten reported that SFPs in MUH were statistically significantly associated with decreases in self-reported exposure to SHS, airborne nicotine levels and particulate matter levels.

Conclusions: Smoke-free policies in multi-unit housing appear to be associated with reduced smoking behavior and second-hand smoke exposure. Successful implementation depends on accessible cessation support and effective enforcement.

背景和目的:尽管在实施无烟政策方面取得了相当大的进展,但许多人继续在家庭环境中接触二手烟。本研究的目的是对多单元住房(MUH)中SFPs与吸烟行为和SHS暴露的关系进行系统评价。方法:于2022年8月检索PubMed、Embase、Web of Science、PsycINFO和CENTRAL 5个在线数据库。关键词包括SFPs、MUH、吸烟行为和SHS暴露。我们搜索了针对普通可燃香烟的研究。由于纳入研究的方法和结果具有高度异质性,因此未进行meta分析。结果:我们的搜索产生了4750篇文章。其中全文检索24份,符合纳入标准17份。所有的研究都是在2001年到2022年之间发表的。大多数研究是在美国进行的(n = 16),采用了横断面设计(n = 7)或纵向设计(n = 7)。七项研究评估了吸烟行为。其中5项研究报告称,高保健患者的SFPs与当前吸烟、吸烟量、吸烟频率或戒烟的减少有统计学显著相关。14项研究评估了SHS暴露。10个国家报告说,在MUH中,SFPs与自我报告的SHS暴露、空气中尼古丁水平和颗粒物水平的降低有统计学意义上的显著关联。结论:多单元住房的无烟政策似乎与减少吸烟行为和二手烟暴露有关。成功实施取决于能否获得戒烟支持和有效执法。
{"title":"Associations of smoke-free policies in multi-unit housing with smoking behavior and second-hand smoke exposure: A systematic review.","authors":"Heike H Garritsen, Farzana Khan, Andrea D Rozema, Ana Navas-Acien, Diana Hernández","doi":"10.1111/add.16724","DOIUrl":"https://doi.org/10.1111/add.16724","url":null,"abstract":"<p><strong>Background and aim: </strong>Although considerable progress has been made regarding the implementation of smoke-free policies (SFPs), many people continue to be exposed to second-hand smoke (SHS) in the home environment. The aim of this study was to conduct a systematic review on the association of SFPs in multi-unit housing (MUH) with smoking behavior and SHS exposure.</p><p><strong>Methods: </strong>In August 2022, we searched five online databases: PubMed, Embase, Web of Science, PsycINFO and CENTRAL. Keywords included terms for SFPs, MUH, smoking behavior and exposure to SHS. We searched for studies that focused on regular combustible cigarettes. Due to the high heterogeneity in methodology and outcomes of the included studies, a meta-analysis was not performed.</p><p><strong>Results: </strong>Our search yielded 4750 articles. All of them were screened (24 based on full-text), and 17 met the inclusion criteria. All studies were published between 2001 and 2022. Most studies were conducted in the United States (n = 16) and used a cross-sectional design (n = 7) or a longitudinal design (n = 7). Seven studies evaluated smoking behavior. Five of them reported that SFPs in MUH were statistically significantly associated with decreases in either current smoking, smoking quantity, smoking frequency or smoking cessation. Fourteen studies evaluated exposure to SHS. Ten reported that SFPs in MUH were statistically significantly associated with decreases in self-reported exposure to SHS, airborne nicotine levels and particulate matter levels.</p><p><strong>Conclusions: </strong>Smoke-free policies in multi-unit housing appear to be associated with reduced smoking behavior and second-hand smoke exposure. Successful implementation depends on accessible cessation support and effective enforcement.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addiction abstract length has been increased to 400 words 成瘾摘要长度增加到400字。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-05 DOI: 10.1111/add.16738

Addiction has increased the maximum word length for abstracts from 300 words to 400 words. The extra length is intended to give authors sufficient space for quantitative estimates in the findings section of the abstract. All inference statements in the findings section (“greater than”, “increased” etc.) should be supported with appropriate estimates and 95% confidence intervals or p-values. The statistics quoted in the abstract should also appear in the body of the paper.

For more information, see our guide to writing abstracts here: https://onlinelibrary.wiley.com/page/journal/13600443/homepage/writing-the-abstract.

{"title":"Addiction abstract length has been increased to 400 words","authors":"","doi":"10.1111/add.16738","DOIUrl":"10.1111/add.16738","url":null,"abstract":"<p><i>Addiction</i> has increased the maximum word length for abstracts from 300 words to 400 words. The extra length is intended to give authors sufficient space for quantitative estimates in the findings section of the abstract. All inference statements in the findings section (“greater than”, “increased” etc.) should be supported with appropriate estimates and 95% confidence intervals or p-values. The statistics quoted in the abstract should also appear in the body of the paper.</p><p>For more information, see our guide to writing abstracts here: https://onlinelibrary.wiley.com/page/journal/13600443/homepage/writing-the-abstract.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":"120 2","pages":"196"},"PeriodicalIF":5.2,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/add.16738","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why it is important to conduct gambling research that is fair and free from conflicts of interest. 为什么进行公平和无利益冲突的赌博研究很重要。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-05 DOI: 10.1111/add.16729
Amanda Roberts, Jim Rogers, Steve Sharman, Sasha Stark, Simon Dymond, Elliot A Ludvig, Richard J Tunney, Matthew O'Reilly, Matthew M Young
{"title":"Why it is important to conduct gambling research that is fair and free from conflicts of interest.","authors":"Amanda Roberts, Jim Rogers, Steve Sharman, Sasha Stark, Simon Dymond, Elliot A Ludvig, Richard J Tunney, Matthew O'Reilly, Matthew M Young","doi":"10.1111/add.16729","DOIUrl":"https://doi.org/10.1111/add.16729","url":null,"abstract":"","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142783361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the association between multiple parental alcohol events and the risk of being maltreated children in a New Zealand population-based birth cohort. 在新西兰以人口为基础的出生队列中评估父母多次饮酒事件与儿童受虐待风险之间的关系
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-04 DOI: 10.1111/add.16727
Jose S Romeo, Taisia Huckle, Vinita Lesley, Nuttanan Wichitaksorn

Background and aims: Child maltreatment is an important component of alcohol's harm to others. No previous studies have assessed the association between multiple parental alcohol events and child maltreatment. This study aimed to measure the impact of parental alcohol-attributable events on the incidence rate of child maltreatment events over the span of childhood and adolescence in New Zealand.

Design, setting and participants: Longitudinal analysis using the birth cohort data of all live births (n = 58 359) in New Zealand in 2000, with the cohort followed until age 17 years using linked data from the Statistics New Zealand Integrated Data Infrastructure (IDI) from 1995 to 2017.

Measurements: Zero-inflated negative binomial and count regression models were used to measure the association between the number of child maltreatment events [collected from publicly funded hospital discharges, Programme for the Integration of Mental Health Data (PRIMHD), Oranga Tamariki, Children's Action Plan (CAP) and police data sets] and parental exposure to alcohol-attributable hospitalization or service use for mental health/addiction. Potential confounders were included for parents and children.

Findings: Of 58 359 children in the cohort, 86% (50 319) had not experienced any documented maltreatment events. Among those at risk of being maltreated children, the maltreatment incidence rate ratio increased by 35.2% (95% confidence interval = 18.1-55.6%) if a child was exposed to parental alcohol-attributable hospitalization or service use for mental health addiction events. For each additional parental alcohol-attributable hospitalization or service use for mental health or addiction, the risk of being maltreated children increased by 12.8%.

Conclusions: In New Zealand, hazardous alcohol consumption by parents appears to be associated with child maltreatment alongside other contributing factors, in particular parental lower educational attainment.

背景和目的:虐待儿童是酒精对他人造成伤害的一个重要组成部分。以前没有研究评估过多次父母酗酒事件与儿童虐待之间的关系。本研究旨在衡量父母酒精归因事件对新西兰儿童期和青春期儿童虐待事件发生率的影响。设计、设置和参与者:使用2000年新西兰所有活产婴儿(n = 58359)的出生队列数据进行纵向分析,使用1995年至2017年新西兰统计局综合数据基础设施(IDI)的关联数据跟踪队列直到17岁。测量方法:使用零膨胀负二项和计数回归模型来测量儿童虐待事件的数量[从公共资助的医院出院、精神健康数据整合方案(PRIMHD)、Oranga Tamariki、儿童行动计划(CAP)和警察数据集收集]与父母因酒精而住院或因精神健康/成瘾而使用服务的情况之间的关联。潜在的混杂因素包括父母和儿童。结果:在队列中的58359名儿童中,86%(50319名)没有经历过任何记录在案的虐待事件。在有被虐待风险的儿童中,如果儿童暴露于父母因酒精导致的住院治疗或心理健康成瘾事件的服务使用,则虐待发生率比增加35.2%(95%置信区间= 18.1-55.6%)。每增加一名因父母酗酒而住院或因心理健康或成瘾而接受服务的儿童,受到虐待的风险就增加12.8%。结论:在新西兰,父母危险饮酒似乎与儿童虐待以及其他因素有关,特别是父母受教育程度较低。
{"title":"Assessing the association between multiple parental alcohol events and the risk of being maltreated children in a New Zealand population-based birth cohort.","authors":"Jose S Romeo, Taisia Huckle, Vinita Lesley, Nuttanan Wichitaksorn","doi":"10.1111/add.16727","DOIUrl":"https://doi.org/10.1111/add.16727","url":null,"abstract":"<p><strong>Background and aims: </strong>Child maltreatment is an important component of alcohol's harm to others. No previous studies have assessed the association between multiple parental alcohol events and child maltreatment. This study aimed to measure the impact of parental alcohol-attributable events on the incidence rate of child maltreatment events over the span of childhood and adolescence in New Zealand.</p><p><strong>Design, setting and participants: </strong>Longitudinal analysis using the birth cohort data of all live births (n = 58 359) in New Zealand in 2000, with the cohort followed until age 17 years using linked data from the Statistics New Zealand Integrated Data Infrastructure (IDI) from 1995 to 2017.</p><p><strong>Measurements: </strong>Zero-inflated negative binomial and count regression models were used to measure the association between the number of child maltreatment events [collected from publicly funded hospital discharges, Programme for the Integration of Mental Health Data (PRIMHD), Oranga Tamariki, Children's Action Plan (CAP) and police data sets] and parental exposure to alcohol-attributable hospitalization or service use for mental health/addiction. Potential confounders were included for parents and children.</p><p><strong>Findings: </strong>Of 58 359 children in the cohort, 86% (50 319) had not experienced any documented maltreatment events. Among those at risk of being maltreated children, the maltreatment incidence rate ratio increased by 35.2% (95% confidence interval = 18.1-55.6%) if a child was exposed to parental alcohol-attributable hospitalization or service use for mental health addiction events. For each additional parental alcohol-attributable hospitalization or service use for mental health or addiction, the risk of being maltreated children increased by 12.8%.</p><p><strong>Conclusions: </strong>In New Zealand, hazardous alcohol consumption by parents appears to be associated with child maltreatment alongside other contributing factors, in particular parental lower educational attainment.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142779027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of personalized and normative feedback via the Positive Play Quiz on responsible gambling intention, self-efficacy and behavior: A randomized controlled trial. 积极游戏测验中个性化和规范性反馈对负责任赌博意图、自我效能感和行为的影响:一项随机对照试验。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-04 DOI: 10.1111/add.16722
Nassim Tabri, Richard T A Wood, Michael J A Wohl

Aims: To evaluate whether a personalized and normative feedback (PNF) intervention for responsible gambling increases gambling insight as well as intention and self-efficacy to engage in responsible gambling and behavioral engagement.

Design: Two-arm randomized controlled trial. Outcome measurements occurred post-randomization and 3 months later.

Setting: Online, Canada.

Participants: Canadian community members who gambled at a land-based casino or online in the last 3 months [61.9% men; mean age = 56.52 (standard deviation = 14.80)] recruited via an online panel (n = 4091).

Intervention and comparator: Participants were randomized to receive PNF (n = 1940) or no feedback (n = 2151).

Measurements: Primary outcomes included gambling insight, intentions and self-efficacy to engage in seven responsible gambling behaviors post-randomization as well as engagement in these behaviors during the 3-month follow-up.

Findings: Post-intervention, participants receiving PNF (relative to no feedback) had greater gambling insight (d = 0.32, P = 4.59e-25) as well as greater intentions and self-efficacy to learn about how the games they play work (dintention = 0.31, P = 4.92e-24; dself-efficacy = 0.25, P = 4.35e-16), learn about the odds of winning at these games (dintention = 0.30, P = 1.43e-21; dself-efficacy = 0.25, P = 2.13e-15) and use operator-provided tools to help limit their gambling (dintention = 0.20, P = 1.36e-10; dself-efficacy = 0.18, P = 3.92e-9). However, post-intervention differences in intention and self-efficacy to limit time and money spent gambling, openness about gambling with others and balancing gambling with other activities were not observed. Meaningful increases in behavioral engagement 3 months later were observed but were not significant.

Conclusions: PNF for responsible gambling (relative to no feedback) appears to increase gambling insight, intentions and self-efficacy to engage in gambling literacy and use of limit-setting tools. Exploratory analyses indicated receiving PNF (relative to no feedback) led to behavioral changes during the 3-month follow-up period.

目的:评估负责任赌博的个性化和规范性反馈(PNF)干预是否能提高负责任赌博的洞察力、参与负责任赌博和行为参与的意愿和自我效能感。设计:两组随机对照试验。结果测量在随机化后和3个月后进行。设置:在线,加拿大。参与者:过去3个月内在陆上赌场或网上赌博的加拿大社区成员[61.9%男性;平均年龄= 56.52岁(标准差= 14.80)]通过在线小组(n = 4091)招募。干预和比较:参与者随机分为接受PNF (n = 1940)和无反馈(n = 2151)两组。测量:主要结果包括随机分组后参与7种负责任赌博行为的赌博洞察力、意图和自我效能,以及3个月随访期间参与这些行为的情况。研究结果:干预后,接受PNF(相对于没有反馈)的参与者有更大的赌博洞察力(d = 0.32, P = 4.59e-25),以及更大的意图和自我效能感,以了解他们玩的游戏是如何运作的(意向= 0.31,P = 4.92e-24;d自我效能= 0.25,P = 4.35e-16),了解在这些游戏中获胜的几率(倾向= 0.30,P = 1.43e-21;自我效能= 0.25,P = 2.13e-15),并使用操作员提供的工具来帮助限制他们的赌博(倾向= 0.20,P = 1.36e-10;自我效能感= 0.18,P = 3.92 -9)。然而,干预后在限制赌博时间和金钱的意愿和自我效能、与他人赌博的开放性以及赌博与其他活动之间的平衡方面没有观察到差异。3个月后观察到行为投入有意义的增加,但并不显著。结论:负责任赌博的PNF(相对于没有反馈)似乎增加了赌博洞察力,意图和自我效能,参与赌博素养和限制设置工具的使用。探索性分析表明,在3个月的随访期间,接受PNF(相对于没有反馈)导致行为改变。
{"title":"Effects of personalized and normative feedback via the Positive Play Quiz on responsible gambling intention, self-efficacy and behavior: A randomized controlled trial.","authors":"Nassim Tabri, Richard T A Wood, Michael J A Wohl","doi":"10.1111/add.16722","DOIUrl":"https://doi.org/10.1111/add.16722","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate whether a personalized and normative feedback (PNF) intervention for responsible gambling increases gambling insight as well as intention and self-efficacy to engage in responsible gambling and behavioral engagement.</p><p><strong>Design: </strong>Two-arm randomized controlled trial. Outcome measurements occurred post-randomization and 3 months later.</p><p><strong>Setting: </strong>Online, Canada.</p><p><strong>Participants: </strong>Canadian community members who gambled at a land-based casino or online in the last 3 months [61.9% men; mean age = 56.52 (standard deviation = 14.80)] recruited via an online panel (n = 4091).</p><p><strong>Intervention and comparator: </strong>Participants were randomized to receive PNF (n = 1940) or no feedback (n = 2151).</p><p><strong>Measurements: </strong>Primary outcomes included gambling insight, intentions and self-efficacy to engage in seven responsible gambling behaviors post-randomization as well as engagement in these behaviors during the 3-month follow-up.</p><p><strong>Findings: </strong>Post-intervention, participants receiving PNF (relative to no feedback) had greater gambling insight (d = 0.32, P = 4.59<sup>e-25</sup>) as well as greater intentions and self-efficacy to learn about how the games they play work (d<sub>intention</sub> = 0.31, P = 4.92<sup>e-24</sup>; d<sub>self-efficacy</sub> = 0.25, P = 4.35<sup>e-16</sup>), learn about the odds of winning at these games (d<sub>intention</sub> = 0.30, P = 1.43<sup>e-21</sup>; d<sub>self-efficacy</sub> = 0.25, P = 2.13<sup>e-15</sup>) and use operator-provided tools to help limit their gambling (d<sub>intention</sub> = 0.20, P = 1.36<sup>e-10</sup>; d<sub>self-efficacy</sub> = 0.18, P = 3.92<sup>e-9</sup>). However, post-intervention differences in intention and self-efficacy to limit time and money spent gambling, openness about gambling with others and balancing gambling with other activities were not observed. Meaningful increases in behavioral engagement 3 months later were observed but were not significant.</p><p><strong>Conclusions: </strong>PNF for responsible gambling (relative to no feedback) appears to increase gambling insight, intentions and self-efficacy to engage in gambling literacy and use of limit-setting tools. Exploratory analyses indicated receiving PNF (relative to no feedback) led to behavioral changes during the 3-month follow-up period.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of proportional pricing on alcohol purchasing in two online experiments. 两个在线实验中比例定价对酒精购买的影响。
IF 5.2 1区 医学 Q1 PSYCHIATRY Pub Date : 2024-12-03 DOI: 10.1111/add.16723
Inge Kersbergen, Amber Copeland, Robert Pryce, Petra Meier, Matt Field

Background and aims: Buying smaller-sized alcohol products can reduce alcohol consumption, but larger products have better value for money, which presents a barrier to switching. We tested whether proportional pricing prompts drinkers to buy smaller alcohol products and reduce alcohol purchasing.

Design, setting and participants: This study was an online experiment set in the United Kingdom, using hypothetical shopping tasks in which participants purchased different-sized products presented under proportional pricing (i.e. constant price per litre throughout all sizes of the same product) or standard pricing conditions. Study 1 (comprising n = 210 participants) was a mixed experiment with pricing condition (proportional pricing, standard pricing; within-subjects) and drink type (lager, red wine, vodka; between-subjects) as manipulated factors. Study 2 (comprising n = 90 participants) was a within-subjects experiment with pricing condition (proportional pricing, standard pricing) and multi-pack type (size difference-only, quantity-difference only, size and quantity difference) as manipulated factors. Participants were UK adult alcohol consumers.

Measurements: We measured outcome variables, including alcohol purchasing (UK units) and proportion of alcohol purchased from smaller products.

Findings: Proportional pricing consistently increased the proportion of alcohol purchased from smaller products [study 1: B = 10.82, 95% confidence interval (CI) = 8.72-12.92; study 2: B = 11.64, 95% CI = 3.50-19.77], indicating a switch to smaller products. However, this did not consistently reduce the total amount of alcohol purchased among drink and product types: proportional pricing reduced the total units purchased from lager multi-packs containing more rather than fewer products (B = -2.56, 95% CI = -4.82 to -0.30), but not from other types of lager multi-packs or single lager products. Proportional pricing also reduced vodka purchasing (B = -3.30, 95% CI = -5.21 to -1.40), but the effect of proportional pricing on wine purchasing was moderated by hazardous drinking (B = -0.11, 95% CI = -0.17 to -0.05).

Conclusions: Alcohol sales policies that require proportional pricing may reduce alcohol purchasing.

背景和目的:购买小尺寸的酒精产品可以减少酒精消费,但大尺寸的产品更物有所值,这对转换构成了障碍。我们测试了比例定价是否会促使饮酒者购买较小的酒精产品并减少酒精购买。设计、设置和参与者:这项研究是在英国进行的一项在线实验,使用假设的购物任务,参与者在比例定价(即同一产品的所有尺寸的每升价格不变)或标准定价条件下购买不同尺寸的产品。研究1(包括n = 210名参与者)是一个定价条件(比例定价、标准定价;受试者内部)和饮料类型(啤酒、红酒、伏特加;受试者之间)作为操纵因素。研究2(包括n = 90名参与者)是一项以定价条件(比例定价、标准定价)和多包装类型(仅尺寸差异、仅数量差异、尺寸和数量差异)为操纵因素的受试者内实验。参与者是英国成年酒精消费者。测量:我们测量了结果变量,包括酒精购买量(英国单位)和从较小的产品中购买的酒精比例。结果:比例定价持续增加了从较小产品中购买酒精的比例[研究1:B = 10.82, 95%可信区间(CI) = 8.72-12.92;研究2:B = 11.64, 95% CI = 3.50-19.77],表明转向较小的产品。然而,这并没有持续减少饮料和产品类型之间的酒精购买总量:比例定价减少了含有更多而不是更少产品的多装啤酒的总购买量(B = -2.56, 95% CI = -4.82至-0.30),但其他类型的多装啤酒或单装啤酒的总购买量没有减少。比例定价也减少了伏特加的购买(B = -3.30, 95% CI = -5.21至-1.40),但比例定价对葡萄酒购买的影响被有害饮酒所调节(B = -0.11, 95% CI = -0.17至-0.05)。结论:要求按比例定价的酒类销售政策可能会减少酒类购买。
{"title":"The effect of proportional pricing on alcohol purchasing in two online experiments.","authors":"Inge Kersbergen, Amber Copeland, Robert Pryce, Petra Meier, Matt Field","doi":"10.1111/add.16723","DOIUrl":"10.1111/add.16723","url":null,"abstract":"<p><strong>Background and aims: </strong>Buying smaller-sized alcohol products can reduce alcohol consumption, but larger products have better value for money, which presents a barrier to switching. We tested whether proportional pricing prompts drinkers to buy smaller alcohol products and reduce alcohol purchasing.</p><p><strong>Design, setting and participants: </strong>This study was an online experiment set in the United Kingdom, using hypothetical shopping tasks in which participants purchased different-sized products presented under proportional pricing (i.e. constant price per litre throughout all sizes of the same product) or standard pricing conditions. Study 1 (comprising n = 210 participants) was a mixed experiment with pricing condition (proportional pricing, standard pricing; within-subjects) and drink type (lager, red wine, vodka; between-subjects) as manipulated factors. Study 2 (comprising n = 90 participants) was a within-subjects experiment with pricing condition (proportional pricing, standard pricing) and multi-pack type (size difference-only, quantity-difference only, size and quantity difference) as manipulated factors. Participants were UK adult alcohol consumers.</p><p><strong>Measurements: </strong>We measured outcome variables, including alcohol purchasing (UK units) and proportion of alcohol purchased from smaller products.</p><p><strong>Findings: </strong>Proportional pricing consistently increased the proportion of alcohol purchased from smaller products [study 1: B = 10.82, 95% confidence interval (CI) = 8.72-12.92; study 2: B = 11.64, 95% CI = 3.50-19.77], indicating a switch to smaller products. However, this did not consistently reduce the total amount of alcohol purchased among drink and product types: proportional pricing reduced the total units purchased from lager multi-packs containing more rather than fewer products (B = -2.56, 95% CI = -4.82 to -0.30), but not from other types of lager multi-packs or single lager products. Proportional pricing also reduced vodka purchasing (B = -3.30, 95% CI = -5.21 to -1.40), but the effect of proportional pricing on wine purchasing was moderated by hazardous drinking (B = -0.11, 95% CI = -0.17 to -0.05).</p><p><strong>Conclusions: </strong>Alcohol sales policies that require proportional pricing may reduce alcohol purchasing.</p>","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142765062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Addiction
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1